Suppr超能文献

利用计算机辅助药物设计靶向筛选姜黄素衍生物作为胰脂肪酶抑制剂

Targeted Screening of Curcumin Derivatives as Pancreatic Lipase Inhibitors Using Computer-Aided Drug Design.

作者信息

Jing Yuxuan, Luo Laichun, Zeng Zhaoxiang, Zhao Xueyan, Huang Rongzeng, Song Chengwu, Chen Guiying, Wei Sha, Yang Haijun, Tang Yinping, Jin Shuna

机构信息

School of Pharmacy, Hubei University of Chinese Medicine, 430065 Wuhan, Hubei, China.

Center of Traditional Chinese Medicine Modernization for Liver Diseases, 430065 Wuhan, Hubei, China.

出版信息

ACS Omega. 2024 Jun 13;9(25):27669-27679. doi: 10.1021/acsomega.4c03596. eCollection 2024 Jun 25.

Abstract

Curcumin has demonstrated promising preclinical antiobesity effects, but its low bioavailability makes it difficult to exert its full effect at a suitable dose. The objective of this study was to screen curcumin derivatives with enhanced bioavailability and lipid-lowering activity under the guidance of computer-aided drug design (CADD). CAAD was used to perform virtual assays on curcumin derivatives to assess their pharmacokinetic properties and effects on pancreatic lipase activity. Subsequently, 19 curcumin derivatives containing 5 skeletons were synthesized to confirm the above virtual assay. The in vitro pancreatic lipase inhibition assay was employed to determine the half-maximal inhibitory concentration (IC) of these 19 curcumin derivatives. Based on CADD analysis and in vitro pancreatic lipase inhibition, 2 curcumin derivatives outperformed curcumin in both aspects. Microscale thermophoresis (MST) experiments were employed to assess the binding equilibrium constants ( ) of the aforementioned 2 curcumin derivatives, curcumin, and the positive control drug with pancreatic lipase. Through virtual screening utilizing a chemoinformatics database and molecular docking, 6 derivatives of curcumin demonstrated superior solubility, absorption, and pancreatic lipase inhibitory activity compared to curcumin. The IC value for 1,7-bis(4-hydroxyphenyl)heptane-3,5-dione (C4), which displayed the most effective inhibitory effect, was 42.83 μM, while the IC value for 1,7-bis(4-hydroxy-3-methoxyphenyl)heptane-3,5-dione (C6) was 98.62 μM. On the other hand, the IC value for curcumin was 142.24 μM. The MST experiment results indicated that the values of C4, C6, and curcumin were 2.91, 18.20, and 23.53 μM, respectively. The results of the activity assays exhibited a relatively high degree of concordance with the outcomes yielded by CADD screening. Under the guidance of CADD, the targeted screening of curcumin derivatives with excellent properties in this study exhibited high-efficiency and low-cost benefits.

摘要

姜黄素已显示出有前景的临床前抗肥胖作用,但其低生物利用度使其难以在合适剂量下发挥全部作用。本研究的目的是在计算机辅助药物设计(CADD)的指导下筛选具有增强生物利用度和降脂活性的姜黄素衍生物。利用CADD对姜黄素衍生物进行虚拟测定,以评估其药代动力学性质及对胰脂肪酶活性的影响。随后,合成了含5种骨架的19种姜黄素衍生物以证实上述虚拟测定。采用体外胰脂肪酶抑制试验来测定这19种姜黄素衍生物的半数最大抑制浓度(IC)。基于CADD分析和体外胰脂肪酶抑制试验,2种姜黄素衍生物在两方面均优于姜黄素。采用微量热泳动(MST)实验评估上述2种姜黄素衍生物、姜黄素及阳性对照药物与胰脂肪酶的结合平衡常数( )。通过利用化学信息学数据库和分子对接进行虚拟筛选,6种姜黄素衍生物相比于姜黄素展现出更优的溶解性、吸收性及胰脂肪酶抑制活性。表现出最有效抑制作用的1,7-双(4-羟基苯基)庚烷-3,5-二酮(C4)的IC值为42.83 μM,而1,7-双(4-羟基-3-甲氧基苯基)庚烷-3,5-二酮(C6)的IC值为98.62 μM。另一方面,姜黄素的IC值为142.24 μM。MST实验结果表明,C4、C6和姜黄素的 值分别为2.91、18.20和23.53 μM。活性测定结果与CADD筛选结果表现出较高程度的一致性。在CADD的指导下,本研究中对具有优异性质的姜黄素衍生物进行靶向筛选展现出高效和低成本的优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6951/11209693/de85cdaf87b1/ao4c03596_0002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验